Search for: "Amgen Inc"
Results 101 - 120
of 702
Sort by Relevance
|
Sort by Date
21 Apr 2022, 10:07 am
Scope and Procedure for the Enablement Requirement: Amgen Inc., et al. v. [read post]
19 Apr 2022, 5:05 am
The Anti-Kickback Statute prohibits offering or accepting kickbacks intended to generate health care business. [read post]
14 Apr 2022, 8:59 pm
By Donald Zuhn –- Earlier today, the Federal Circuit reversed the Final Written Decision, and reconsideration of that decision, by the U.S. [read post]
17 Mar 2022, 2:32 pm
See Amgen Inc. v. [read post]
24 Feb 2022, 6:12 pm
” Full Scope Enablement: Amgen v. [read post]
2 Feb 2022, 4:15 am
Inc., 941 F.3d 1149 (Fed. [read post]
2 Jan 2022, 4:38 pm
on January 13, 2022 Senior Counsel - Strategic Transactions - Mergers and Acquisitions (Remote US) at Amgen (Boston, MA) on January 13, 2022 Senior Counsel - Strategic Transactions - Mergers and Acquisitions (Remote US) at Amgen (Charlotte,... [read post]
14 Dec 2021, 9:57 am
Dropbox, Inc., No. 21-812. [read post]
18 Nov 2021, 9:19 am
A U.S. judge denied Apple Inc’s efforts to pause an injunction handed down after an antitrust case brought by “Fortnite” creator Epic Games. [read post]
6 Nov 2021, 9:15 pm
In the second installment of a three part series, Emily Johnson of Amgen, Inc., Jay Tatachar of Ericsson, Vaishali Udupa of Hewlett Packard Enterprise, Todd Walters of Buchanan Ingersoll & Rooney PC, and Jenifer Ward General Electric Co. will discuss the pros and cons of the various options for challenging the validity of patent claims, giving perspectives from both challenger and patent owner, and highlight... [read post]
6 Nov 2021, 9:15 pm
In the second installment of a three part series, Emily Johnson of Amgen, Inc., Jay Tatachar of Ericsson, Vaishali Udupa of Hewlett Packard Enterprise, Todd Walters of Buchanan Ingersoll & Rooney PC, and Jenifer Ward General Electric Co. will discuss the pros and cons of the various options for challenging the validity of patent claims, giving perspectives from both challenger and patent owner, and highlight... [read post]
26 Aug 2021, 1:05 pm
Cir. 2001) (citation omitted); Amgen Inc. v. [read post]
13 Aug 2021, 7:41 am
Nelson, J.D.The Supreme Court in June 2021 remanded Arkansas Teacher Retirement System’s securities fraud case against Goldman Sachs Group, Inc. so that the Second Circuit could reconsider the generic nature of alleged misstatements made by Goldman Sachs about its ability to police conflicts of interest that were the basis for the suit. [read post]
15 Jul 2021, 2:54 pm
In its June 21, 2021 decision in Goldman Sachs Group, Inc. v. [read post]
15 Jul 2021, 10:15 am
(now named Anthem, Inc.) and Amgen Inc. [read post]
25 Jun 2021, 4:15 am
On June 21, the United States Court of Appeals for the Federal Circuit (CAFC) denied a petition for rehearing and rehearing en banc filed by Amgen Inc., Amgen Manufacturing, Limited, and Amgen USA, Inc. [read post]
25 Jun 2021, 4:15 am
On June 21, the United States Court of Appeals for the Federal Circuit (CAFC) denied a petition for rehearing and rehearing en banc filed by Amgen Inc., Amgen Manufacturing, Limited, and Amgen USA, Inc. [read post]
8 May 2021, 10:26 pm
The panel will cover recent developments in the Hatch-Waxman and BPCIA litigation and legislation, in particular, the Federal Circuit decisions in Amgen Inc. v. [read post]
2 May 2021, 1:41 pm
PatentlyOreported on the case of Amgen Inc. v. [read post]
29 Apr 2021, 6:39 am
Inc., 959 F.3d 1091 (Fed. [read post]
